Myeloma Minute: New Drug Updates


| INNOVATION | Latest Research


New Drug Updates and Notes on the Environment

Reports from the frontlines of drug development—from selinexor to daratumumab—have dominated myeloma news recently. IMF Chairman Dr. Brian G.M. Durie explains what it all means for myeloma patients. He also takes a look at the week’s top environmental-impact stories.


| INSPIRATION | Stronger Together


We Can All Be Warriors

Ron Hood draws strength from being a Myeloma Warrior. At the 2018 Brian D. Novis Research Grant Awards reception, a night filled with hope held annually during the American Society of Hematology meeting, Ron movingly described his experiences living with the disease and the ways in which the IMF has supported him along the way. As Ron says, “When our health fails us, that’s a challenge, but it also provides us with one of those important opportunities to show that we can be Warriors together.” Read a transcript of his speech now, and see how Ron is an inspiration for us all.


| EDUCATION | Workshop


| EDUCATION | Seminar


Register Now for a Regional Community Workshop in Seattle
Register Now for the IMF’s Patient & Family Seminar in Short Hills, NJ

The IMF will host a Regional Community Workshop at the Seattle Marriott Waterfront (2100 Alaskan Way) in Seattle on Saturday, April 6, 2019. Registration is FREE, but seating is limited. Learn from and meet one-on-one with myeloma experts to get answers to your questions and concerns.

The IMF Patient & Family Seminar in Short Hills, New Jersey, takes place April 5 - 6, 2019, at the Hilton Short Hills (41 JFK Parkway). During this seminar, learn about the latest treatments for and the management of multiple myeloma. The IMF Patient & Family Seminars are a wonderful opportunity to exchange valuable information, visit with friends, and share true-life experiences.

Register Now Button.png

Register Now Button.png

| EDUCATION | Teleconference


Register Now for the Next “Living Well with Myeloma” Teleconference

On Thursday, April 25, 2019 at 4:00 p.m. PST / 7:00 p.m. EST, Dr. Brian G.M. Durie, IMF Chairman of the Board, hosts a “Living Well with Myeloma” teleconference. The focus of the teleconference will be on early disease management, including criteria for diagnosis and best treatment options. Patients are increasingly diagnosed early and must be certain if decisive first therapy is appropriate or if observation is recommended. With the introduction of new therapies, many options are to be reviewed and considered for patients in each risk group and with assessment for age and comorbidities. Current best treatment guidelines will be presented.

Register Now Button.png

| ACTION | Calling All Myeloma Warriors


Donate Your Birthday During This Year’s MAM

During March, if you donate your birthday or any event on the IMF’s Facebook page, your donation may be doubled. For this year’s Myeloma Action Month, Janssen Oncology (one of our sponsors) will match up to $10,000 of Facebook donations benefiting the International Myeloma Foundation. Donating your birthday is one of the simplest ways to host your own fundraiser and double every dollar you raise to support the IMF!


| #ASKDRDURIE | Dr. Durie's Weekly Web Video Series



New isatuximab Clinical Trial: the IMROZ Study

New isatuximab Clinical Trial: the IKEMA Study

Join the conversation about myeloma on the Smart Patients Message Board

March 23, 2019
Regional Community Workshop
La Jolla, CA

April 5-6, 2019
IMF Patient & Family Seminar
Short Hills, NJ

April 6, 2019
Regional Community Workshop
Seattle, WA

April 27, 2019
2019 Miles for Myeloma 5K Run/Walk
Philadelphia, PA

subscribe_button.png          donate_button_bottom.png
We Thank Our Sponsors:
Amgen, Celgene Corporation, Genentech, Sanofi-Genzyme, and Takeda Oncology
and individuals like you who supported the IMF this year

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.